Nivolumab Combined With Brentuximab Vedotin for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma: Efficacy and Safety From the Phase II CheckMate 436 Study.
暂无分享，去创建一个
N. Johnson | P. Zinzani | J. Kuruvilla | G. Gritti | P. Brice | J. Kline | N. Mehta-Shah | A. Moskowitz | P. Barr | S. Francis | D. Cunningham | T. Manley | M. Sharma | A. Santoro | P. Zinzani | Armando Santoro | David Cunningham | Justin Kline | Nathalie A. Johnson | Thomas Manley | Manish Sharma | A. Santoro